Taken together these reports paint a complex picture of the cellular role of SigmaR1, and suggest that its effect on breast cancer is context-dependent, and likely acting through yet-to-be-identified oncoprotein(s) and/or other mechanisms that favor cancer cell proliferation or survival such as modulation of energetic, apoptotic and autophagic pathways. Here, SIGMAR1 is linked to breast cancer.